Kei Miyamoto
- Ophthalmology top 1%
- Molecular Biology top 5%
- Pluripotent Stem Cells Research 30
- CRISPR and Genetic Engineering 14
- Epigenetics and DNA Methylation 9
- Renal and related cancers 9
- Genomics and Chromatin Dynamics 8
- RNA Research and Splicing 8
- Cell Biology top 5%
-
- Reproductive Biology and Fertility 28
- Immunology and Allergy top 10%
-
- Animal Genetics and Reproduction 10
- Co-authors
- J. B. GurdonJérôme JullienVincent PasqueAkitaka TsujikawaNaoko HiroshibaYasuhiro OguraRichard P. Halley‐StottYuichiro Ogura
- Journals
- Science (1 paper)Proceedings of the National Academy of Sciences (1 paper)Journal of the American Chemical Society (1 paper)
- Partner nations
- JapanUnited KingdomUnited States
In The Last Decade
Kei Miyamoto
85 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 116
- Ophthalmology 498
- Molecular Biology 1.8k
- Cell Biology 323
- Public Health, Environmental and Occupational Health 493
- Immunology and Allergy 87
Countries citing papers authored by Kei Miyamoto
This map shows the geographic impact of Kei Miyamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kei Miyamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kei Miyamoto more than expected).
Fields of papers citing papers by Kei Miyamoto
This network shows the impact of papers produced by Kei Miyamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kei Miyamoto. The network helps show where Kei Miyamoto may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kei Miyamoto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 10 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 4 | |
| 4 | 2022 | 1 | |
| 5 | 2021 | 5 | |
| 6 | 2021 | 11 | |
| 7 | 2020 | 42 | |
| 8 | 2019 | 14 | |
| 9 | 2019 | 39 | |
| 10 | 2018 | 26 | |
| 11 | 2017 | 161 | |
| 12 | 2015 | 10 | |
| 13 | 2012 | 35 | |
| 14 | 2012 | 40 | |
| 15 | 2011 | 138 | |
| 16 | 2009 | 59 | |
| 17 | 2008 | 38 | |
| 18 | 2008 | 46 | |
| 19 | Retinal ischemia-reperfusion injury attenuated by blocking of adhesion molecules of vascular endothelium. | 1999 | 66 |
| 20 | 1992 | 2 |
About Kei Miyamoto
Kei Miyamoto is a scholar working on Public Health, Environmental and Occupational Health, Ophthalmology and Molecular Biology, having authored 86 papers that have together received 2.6k indexed citations. Recurring topics across this work include Pluripotent Stem Cells Research (30 papers), Reproductive Biology and Fertility (28 papers), CRISPR and Genetic Engineering (14 papers), Animal Genetics and Reproduction (10 papers), Epigenetics and DNA Methylation (9 papers), Renal and related cancers (9 papers), Genomics and Chromatin Dynamics (8 papers) and RNA Research and Splicing (8 papers). The work is most often cited by research in Ophthalmology (498 citations), Molecular Biology (1.8k citations) and Cell Biology (323 citations). Kei Miyamoto has collaborated with scholars based in Japan, United Kingdom and United States. Frequent co-authors include J. B. Gurdon, Jérôme Jullien, Vincent Pasque, Akitaka Tsujikawa, Naoko Hiroshiba, Yasuhiro Ogura, Richard P. Halley‐Stott, Yuichiro Ogura, Marta Teperek and Junichi Kiryu. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.